Clinical Trial Update: PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC

View source ↗

Summary

This clinical trial update describes the PEMBRO-K study evaluating therapeutic pharmacological monitoring with pembrolizumab in non-small cell lung cancer, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University Hospital, Angers | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING